50% off Premium Yearly

NYSE:MET
This summary was created by AI, based on 1 opinions in the last 12 months.
MetLife (MET-N) has demonstrated strong performance recently, as indicated by its recent achievement of a 52-week high. The company is viewed favorably by experts for its strategic investments in solid and conservative sectors, which add to its appeal as a defensive stock. This positive sentiment suggests that MetLife is successfully navigating the financial landscape, with a focus on stability and sustainability. Investors seem to appreciate its prudent approach to asset management and its ability to deliver reliable returns in uncertain market conditions. Overall, MetLife stands out as a robust option for investors seeking defensive plays in their portfolios.
Metlife is a American stock, trading under the symbol MET (previously MET-N on Stockchase) on the New York Stock Exchange (MET). It is usually referred to as NYSE:MET or MET
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on MET (previously MET-N on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is DON'T BUY. Read the latest stock experts' ratings for Metlife.
Metlife was recommended as a Top Pick by Brian Acker, CA on 2019-06-14. Read the latest stock experts ratings for Metlife.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Metlife.
Metlife is followed by 36 investors on Stockchase and is a trending stock that is worth watching.
On 2026-06-16, Metlife (MET) stock closed at a price of $87.86.
Just made a 52-week high. Solid, conservative and defensive, invested in the right things.